Pablo Muriel

7.6k total citations · 2 hit papers
137 papers, 5.8k citations indexed

About

Pablo Muriel is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Pablo Muriel has authored 137 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Epidemiology, 67 papers in Hepatology and 52 papers in Pharmacology. Recurrent topics in Pablo Muriel's work include Liver Disease Diagnosis and Treatment (70 papers), Drug-Induced Hepatotoxicity and Protection (51 papers) and Liver Disease and Transplantation (45 papers). Pablo Muriel is often cited by papers focused on Liver Disease Diagnosis and Treatment (70 papers), Drug-Induced Hepatotoxicity and Protection (51 papers) and Liver Disease and Transplantation (45 papers). Pablo Muriel collaborates with scholars based in Mexico, United States and Spain. Pablo Muriel's co-authors include Erika Ramos‐Tovar, Marisabel Mourelle, Mineko Shibayama, Erika Hernández‐Aquino, Víctor Pérez-Álvarez, Yadira Rivera‐Espinoza, Vı́ctor Tsutsumi, José Segovia, Jonathan Arauz and Karina Reyes‐Gordillo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Brain Research.

In The Last Decade

Pablo Muriel

135 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Beneficial effects of naringenin in liver diseases: Molecular mechanisms

2018 284 citations Erika Hernández‐Aquino, Pablo Muriel profile →
Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver

2020 217 citations Erika Ramos‐Tovar, Pablo Muriel profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pablo Muriel Mexico	42	1.9k	1.8k	1.5k	1.4k	538	137	5.8k
Hor‐Yue Tan Hong Kong	45	1.4k 0.7×	1.3k 0.7×	490 0.3×	3.5k 2.5×	531 1.0×	105	7.7k
Alain Berson France	36	1.4k 0.7×	1.3k 0.7×	603 0.4×	1.3k 0.9×	377 0.7×	59	3.9k
Philip R. Mayeux United States	35	961 0.5×	1.4k 0.8×	569 0.4×	1.3k 0.9×	197 0.4×	68	5.1k
Sung Hwan Ki South Korea	41	2.0k 1.1×	707 0.4×	548 0.4×	2.6k 1.9×	633 1.2×	117	6.0k
Sun‐Mee Lee South Korea	44	962 0.5×	1.1k 0.6×	516 0.4×	2.1k 1.5×	313 0.6×	157	5.3k
Zhenzhou Jiang China	44	1.2k 0.6×	1.2k 0.7×	444 0.3×	2.8k 2.0×	305 0.6×	266	6.6k
Amin A. Nanji United States	45	2.9k 1.5×	949 0.5×	964 0.7×	1.7k 1.2×	880 1.6×	196	6.9k
Huijun Sun China	45	1.0k 0.6×	1.0k 0.6×	328 0.2×	2.4k 1.7×	527 1.0×	198	6.1k
Mitchell R. McGill United States	42	1.9k 1.0×	4.4k 2.4×	2.3k 1.6×	1.7k 1.2×	189 0.4×	100	7.1k
Ramiro Jover Spain	43	1.1k 0.6×	1.8k 1.0×	796 0.5×	1.9k 1.4×	502 0.9×	116	5.4k

Countries citing papers authored by Pablo Muriel

Since Specialization

Citations

This map shows the geographic impact of Pablo Muriel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Muriel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Muriel more than expected).

Fields of papers citing papers by Pablo Muriel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Muriel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Muriel. The network helps show where Pablo Muriel may publish in the future.

Co-authorship network of co-authors of Pablo Muriel

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Muriel. A scholar is included among the top collaborators of Pablo Muriel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Muriel. Pablo Muriel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramos‐Tovar, Erika, et al.. (2025). Naringenin attenuates early hepatocarcinogenesis induced by a MASH model. Annals of Hepatology. 30(2). 101897–101897. 1 indexed citations

Muriel, Pablo, et al.. (2025). Involvement of the hedgehog signaling pathway in liver diseases. Annals of Hepatology. 30(2). 102148–102148.

Casas‐Grajales, Sael, et al.. (2024). Effect of Stevioside (Stevia rebaudiana) on Entamoeba histolytica Trophozoites. Pathogens. 13(5). 373–373. 1 indexed citations

Galicia‐Moreno, Marina, Hugo Christian Monroy-Ramírez, Pablo Muriel, et al.. (2024). A new opportunity for N-acetylcysteine. An outline of its classic antioxidant effects and its pharmacological potential as an epigenetic modulator in liver diseases treatment. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(3). 2365–2386. 5 indexed citations

Mayoral, Laura Pérez‐Campos, et al.. (2024). Discovery of candidate biomarkers from plasma-derived extracellular vesicles of patients with cirrhosis and hepatocellular carcinoma: an exploratory proteomic study. Molecular Omics. 20(7). 483–495. 3 indexed citations

Baltiérrez‐Hoyos, Rafael, Rebeca García‐Román, José Luis Pérez-Hernández, et al.. (2023). Identification of ABCC3 and its isoforms as potential biomarker in hepatocellular carcinoma. Toxicology Mechanisms and Methods. 34(4). 398–407. 1 indexed citations

Ramos‐Tovar, Erika, Erika Hernández‐Aquino, Sael Casas‐Grajales, et al.. (2018). Stevia Prevents Acute and Chronic Liver Injury Induced by Carbon Tetrachloride by Blocking Oxidative Stress through Nrf2 Upregulation. Oxidative Medicine and Cellular Longevity. 2018(1). 3823426–3823426. 46 indexed citations

Galicia‐Moreno, Marina, Liliana Favari, & Pablo Muriel. (2011). Trolox mitigates fibrosis in a bile duct ligation model. Fundamental and Clinical Pharmacology. 27(3). 308–318. 12 indexed citations

Galicia‐Moreno, Marina, Karina Reyes‐Gordillo, José Segovia, et al.. (2009). N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress. European Journal of Gastroenterology & Hepatology. 21(8). 908–914. 41 indexed citations

10.

Fernández‐Martínez, Eduardo, Nury Pérez‐Hernández, Pablo Muriel, et al.. (2008). The thalidomide analog 3-phthalimido-3-(3,4-dimethoxyphenyl)-propanoic acid improves the biliary cirrhosis in the rat. Experimental and Toxicologic Pathology. 61(5). 471–479. 5 indexed citations

11.

Fernández‐Martínez, Eduardo, Martha S. Morales‐Ríos, Víctor Pérez-Álvarez, & Pablo Muriel. (2004). Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat. Biochemical Pharmacology. 68(7). 1321–1329. 31 indexed citations

12.

García‐Benavides, Leonel, Ana Sandoval-Rodríguez, Adriana Salazar, et al.. (2002). Pirfenidone effectively reverses experimental liver fibrosis. Journal of Hepatology. 37(6). 797–805. 148 indexed citations

13.

Muriel, Pablo, et al.. (2000). Hepatic basolateral plasma high-affinity Ca2+-ATPase is inhibited by nitric oxide and peroxynitrite anion. Journal of Applied Toxicology. 20(6). 435–439. 12 indexed citations

14.

Muriel, Pablo, et al.. (1997). Trimethylcolchicinic Acid Decreases Liver Fibrosis and Cholestasis Induced by Prolonged Biliary Obstruction in the Rat. Journal of Applied Toxicology. 17(3). 145–151. 5 indexed citations

15.

Muriel, Pablo, et al.. (1997). Dose-Response Studies of Interferon-α<sub>2b</sub> on Liver Fibrosis and Cholestasis Induced by Biliary Obstruction in Rats. Pharmacology. 54(4). 179–185. 12 indexed citations

16.

Mourelle, Marisabel, et al.. (1996). Effect of Colchicine and Trimethylcolchicinic Acid on CCl₄‐Induced Cirrhosis in the Rat. Pharmacology & Toxicology. 79(5). 241–246. 8 indexed citations

17.

Rodríguez‐Fragoso, Lourdes, et al.. (1995). Interf eron-α<sub>2b</sub> Increases Fibrolysis in Fibrotic Livers from Bile Duct Ligated Rats: Possible Participation of the Plasminogen Activator. Pharmacology. 51(6). 341–346. 12 indexed citations

18.

Bobadilla-Lugo, Rosa A., et al.. (1993). Effects of Leukotriene Synthesis Inhibition on Acute Liver Damage Induced by Carbon Tetrachloride. Pharmacology. 47(5). 330–336. 20 indexed citations

19.

Muriel, Pablo. (1993). Effect of S-adenosyl-l-methionine on liver damage induced by biliary obstruction. Hepatology. 18(4). A319–A319. 1 indexed citations

20.

Mourelle, M, Pablo Muriel, Liliana Favari, & Telma Teixeira Franco. (1989). PREVENTION OF CCL₄‐INDUCED LIVER CIRRHOSIS BY SILYMARIN. Fundamental and Clinical Pharmacology. 3(3). 183–191. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact